Mai Capital Management Bio Rad Laboratories, Inc. Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Mai Capital Management holds 14 shares of BIO stock, worth $3,132. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 21
33.33%
Holding current value
$3,132
Previous $6,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$428 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$350 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$347 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$204 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$196 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.51B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...